Glaxosmithkline Share News (GSK)

LONDON BROKER RATINGS: Jefferies downgrades three utility stocks

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

LONDON BROKER RATINGS: Peel Hunt puts Morses Club rating under review

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

FTSE 100 records biggest weekly fall in 3 months on high inflation, Ukraine risks

Feb 18 (Reuters) - UK's FTSE 100 fell on Friday as weakness in healthcare stocks and simmering Russia-Ukraine tensions offset optimism around better-than-expected January retail sales data, while the benchmark stock index recorded its biggest weekly drop in three months.

LONDON BROKER RATINGS: Berenberg says buy Aveva, Deutsche says hold

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

GSK pauses trial of respiratory virus vaccine in pregnant women

Feb 18 (Reuters) - GSK has paused a late-stage trial of its vaccine candidate against the respiratory syncytial virus (RSV) in pregnant women based on safety recommendations from an independent committee, the British drugmaker said on Friday.

LONDON MARKET PRE-OPEN: Natwest posts 2021 profit, plans share buyback

(Alliance News) - Stocks in London are set to steady on Friday at the end of a difficult week dominated by headlines about the Russia-Ukraine crisis.

Glaxo pauses enrolment and vaccination in RSV vaccine candidate trials

(Sharecast News) - Drugmaker GlaxoSmithKline has voluntarily paused enrolment and vaccination in the GRACE phase III trial evaluating its potential respiratory syncytial virus maternal vaccine candidate, as well as two other trials of the candidate in pregnant women.

UK dividends calendar - next 7 days

Director dealings: GSK execs sell shares for tax bills, Airtel director makes £50k purchase

(Sharecast News) - GlaxoSmithKline disclosed a number of executive awards on Thursday, with two of its directors making large sales to cover their tax bills.

Nestle says "low interest" in broad consumer health care portfolio

ZURICH, Feb 17 (Reuters) - Nestle wants to focus on nutrition and metabolism for its health science business rather than building a broad health care portfolio, its chief executive told investors on Thursday.

LONDON BROKER RATINGS: RBC lifts Unilever and cuts BAT

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

IN BRIEF: GSK consumer chief sells USD2.5 million in Glaxo shares

GlaxoSmithKline PLC - Brentford, England-based pharmaceuticals - Brian McNamara, chief executive officer of GSK Consumer Healthcare, sells 55,000 American Depositary Shares at USD44.99, worth USD2.5 million, in New York on Thursday. Each ADS represents two Glaxo ordinary shares. Back in July of last year, McNamara, who already headed the consumer business, a joint venture with Pfizer Inc, was appointed a CEO of the demerged company. Glaxo intends a listing for GSK Consumer Healthcare, having rejected three takeover offers for the business from Unilever PLC.

China approves Glaxo's Benlysta lupus treatment for further use

China approves Glaxo's Benlysta lupus treatment for further use

Glaxo's Benlysta lupus treatment approved in China for adults

(Sharecast News) - GlaxoSmithKline said on Thursday that Benlysta (belimumab) has been approved in China for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard of care.

LONDON BROKER RATINGS: RBC raises B&M European Value to sector perform

LONDON BROKER RATINGS: RBC raises B&M European Value to sector perform